AFP Critical Appraisal & Stats Flashcards
(118 cards)
1
Q
How will you summarise what the paper is about?
A
Population = People with AF
Intervention = Apixaban 5mg BD
Control = Warfarin INR 2-3
Outcomes = Stroke or systemic embolism
Key findings
2
Q
What should you think about before summarising the paper?
A
QR
What is the research q and what is its relevance to clinical practise
3
Q
What acronym do you use to assess internal validity?
A
Recruitment
Allocation
Maintenance
Baseline
Outcome (and was it blinded)
Stats
4
Q
What is internal validity?
A
The extent to which the observed results represent the truth in the population we are studying and, thus, are not due to methodological errors
5
Q
How can we reduce selection bias?
A
Use consecutive recruitment rather than non-consecutive
Consider the recruitment location (e.g. GP vs hospital)
6
Q
What types of recruitment are there?
A
Consecutive vs non-consecutive
Single centre vs multicentre
7
Q
Types of allocation?
A
Randomised vs non randomised
Allocation blinded vs open label
Letters/Packets vs automated voice recognition system (electronic)
Block randomisation vs whole group randomisation
Cluster randomisation vs whole group randomisation
8
Q
What is block randomisation?
A
Wait for X number of study participants and then say 50% go to each arm
Throughout the whole study there are equal numbers in both arms
Helps to mitigate temporal trends
9
Q
What is cluster randomisation? Disadvantages?
A
Used in multicentre studies
Used when you can’t deliver different interventions in one place (e.g. poster in a GP practice)
Needs higher numbers of people
More difficult to achieve balance across groups
10
Q
Benefit of randomisation?
A
Reduces risk of confounders
11
Q
Why does blinding help?
A
Reduces risk of placebo effect
Reduces bias in data analysis
12
Q
Benefit of Electronic voice recognition system?
A
Minimizes risk of tampering
13
Q
What is study maintenance and what is usually aimed for?
A
Maintenance is the drop out rate from a study
Usually aim for <20% but ideally <10%
14
Q
What bias is created if there is a poor maintenance?
A
Attrition bias - causes study to be under powered
15
Q
Types of blinded outcome?
A
Single: patient only
Double: patient and physicians interacting
Triple: patient, physicians, outcome extractors
16
Q
How can you blind if the outcome can’t be blinded e.g. surgical?
A
Use PROBE design
Prospective Randomised Open label Blinded endpoint adjudication
Whoever reviews the outcomes doesn’t know which arm of study the patient is in (e.g. radiologist when looking at stroke tx)
17
Q
What do you need to look at in baseline?
A
Baseline characteristics of population and are they matched?
18
Q
Besides blinding what else do you need to consider with outcome?
A
Is the choice of outcome important, adequate and important to patients?
19
Q
Define power
A
the likelihood of detecting a difference when it exists (avoiding Type 2 error)
20
Q
What 4 things should we look at when analysing the stats of a paper?
A
Power calculation and according recruitment target
Statistical models used for outcome measure (binary, continuous, time-dependent)
Effect size and significance level
Absolute risk reduction / Relative risk reduction / NNT
21
Q
What 3 things does power calculation depend on?
A
- How many events are expected over follow-up time (incidence x time) - increase sample size
- Expected improvement (RRR of 50%) - increase effect size
- What probability you want to detect the difference when it exists (80%?) - increase precision of measurement
If a study is negative then think about the power!
22
Q
Define p value
A
probability that the association detected has arisen by chance
23
Q
How to strengthen the p value?
A
Size of association
Size of cohort
24
Q
What test do you use to calculate difference between 2 groups with categorical variables when not adjusted? E.g. stroke vs no stroke
A
Chi-squared
25
What test do you use to calculate difference between 2 groups with categorical variables when adjusted? E.g AF X Stroke
Binary logistic regression
26
What test do you use for comparing 2 groups with a continuous outcome e.g. Gender x BMI if normally distributed?
T-test
27
What test do you use for comparing 2 groups with a continuous outcome e.g. Gender x BMI if not normally distributed?
Wilcoxon ranked test/Mann Whitney U
28
What test do you use for comparing >2 groups with a continuous outcome e.g. number of children x BMI if adjusted?
ANOVA
29
What test do you use for comparing >2 groups with a continuous outcome e.g. number of children x BMI if not adjusted?
ANCOVA
30
What test do you use to find a correlation between 2 parametric continuous variables?
Pearson's rank
31
What test do you use to find a correlation between 2 non-parametric continuous variables?
Spearman's rank
32
What test to use for time to event data i.e. when time counts (e.g. mortality in cancer tx) to determine a direct association?
Kaplan Meier analysis
33
What test to use for time to event data i.e. when time counts (e.g. mortality in cancer tx) when adjusted for covariates?
Cox proportional hazards model
34
How to assess external validity?
Resources - equipment/cost
Population - can you generalise the demographics
35
What are the last 3 things we consider?
Funding - any conflicts of interest
Ethics - clinical equipoise, safety outcomes, data safety monitoring board
Conclusion
36
Define 95% Confidence interval
A range, between which the population mean value will lie 95% of the time
37
Define relative risk
Risk of developing disease in the exposed group compared to the risk of developing disease in the unexposed group
38
How do you calculate relative risk?
Those who got disease in exposed group/all exposed divided by those who got disease in non-exposed group/all non-exposed
39
Which studies is relative risk used in?
Prospective cohort
40
Define odds ratio?
Odds of something happening vs the odds of it not happening
41
How do you calculate odds ratio?
Exposed with disease/not exposed with disease divided by exposed without disease/not exposed without disease
AKA odds in disease group/odds in control
42
What studies is odds ratio used in?
Retrospective observational study (case-control study)
43
Define hazard ratio
Used to look at survival over time with a Kaplan Meier curve - equivalent to relative risk but risk is not constant with respect to time
44
What is a hazard ratio used in?
Prospective RCT
45
Define incidence rate
Number of new cases over a defined period of time
46
Define prevalence
Number of cases in a given population at any given time
47
Define Absolute risk reduction (ARR) and how to calculate it
Difference in the incidence of disease between two groups
= P(event occurring in group 1) – P(event occurring in group 2)
48
Define NNT and how to calculate it
Number of patients who need to be treated to prevent one event occurring
= 1/ARR
49
How to calculate RRR?
= ARR / P(event occurring in control group)
Express as %
50
Define Type I error
Probability of rejecting H0 when in fact H0 is true
i.e. probability of concluding there is a significant difference when actually there’s no difference.
False positive
51
Define Type II error
Probability of concluding H0 is true when in fact it is FALSE
i.e. false negative
52
How do we set a type II error?
β is the probability of making type II error – usually set at 0.8
53
How do we set a type I error?
Reflects p value cut-off i.e. usually = 0.05.
54
What does per protocol analysis mean?
What is the benefit?
What is the con?
Only participants who complied with study protocol completely are included in analysis.
More accurate representation of treatment effect
Susceptible to attrition bias and exclusion bias
55
What does intention to treat analysis involve?
What is the benefit?
What is the con?
All participants who have been randomised are included, regardless if they took the medicine / completed the study
More accurate representation of effect in clinical practice
Can't determine what the drug does in optimal conditions
56
What are case control studies used for?
Identifying associations between exposure and outcome
57
Advantages of case control studies?
Rare diseases
Quicker and cheaper to perform
Can analyse multiple exposures at once
Can calculate OR
Good for dynamic populations where follow up is difficult
58
Disadvantages of case control studies?
Rely on quality of records
Selection bias and recall bias
Can't demonstrate temporal association
59
What is a cohort study used for?
Evidence for causation and temporal association
60
Advantages of cohort studies?
Assess temporality
Assess prognosis
Can control data collection and quality
Can calculate incidence – allows you to calculate RR, risk difference, NNT
Good for common exposures
61
Disadvantages of cohort studies?
Expensive
Take longer
Not good for rare diseases
Loss to follow-up and potential of attrition bias
Can be affected by confounders
62
Define bias
Factors which cause systematic over or under-estimate of a particular result
63
What is selection bias?
Systematic differences between the baseline characteristics of the groups (minimised by randomisation)
Study sample does not represent entire population
64
What is Berkson bias?
Form of selection bias, in which the sample is taken from a subpopulation (not the general population)
For example, participants being recruited from the hospital, rather than also community settings
65
What is volunteer bias?
People who volunteer are different from population as a whole
66
What is channelling bias?
Healthcare professionals may subconsciously select patients who would be good for study
67
What is performance bias?
Systematic differences between groups in care provided other than the intervention of interest (minimised by blinding and having set protocol)
68
What is detection bias?
Systematic differences between groups in how outcomes are determined (minimised by blinding and having objective outcomes and standardising assessment)
69
What is Interview bias?
If interviewer already knows disease status of participant
70
What is recall bias?
A systematic error caused by differences in the accuracy of recollections retrieved by study participants
71
What is Hawthorne bias?
Participants alter behaviour because they are aware of monitoring
72
What is attrition bias?
Systematic differences in withdrawals from the trial
Reduced by intention-to-treat analysis
73
What is a confounder?
A factor which has an independent effect on both the exposure and the outcome
74
How can we minimise confounders?
Stratification of participant groups
Regression analysis
Randomisation and matching
75
What is external validity?
Generalisability of results
76
Difference between RR and HR
RR looks at if an event has occurred during the study
HR looks at if an event occurred and when it occurred
77
How to describe RR of 1.45?
45% more likely to have outcome X
78
How to describe OR of 1.6?
Odds of exposure to factor X is 1.6x higher
79
How to describe HR of 0.79?
At any particular point, group A were 21% less likely to have outcome X
80
What is a type 1 error?
Reject H0 (no difference) when actually H0 is true
I.e. False positive
81
What is a type 2 error?
False negative
82
Define sensitivity and how to calculate it
Probability of correctly identifying those with disease
TP/TP + FN
83
Define specificity and how to calculate it
Probability of correctly identifying those without disease
TN/TN + FP
84
What is a QALY? What is the accepted cost?
Quality adjusted life year
<20k per QALY – ACCEPT. 20-30 – think about
85
What is a fixed effect meta analysis?
Assumes that studies are homogenous
All measuring same treatment effect
Calculate weighted average - give more weight to bigger studies
86
What is a random effects meta?
Assumes heterogeneity between studies
87
What methods are used to quantify heterogeneity?
Q – statistic - low p = heterogenetic
I2 – estimates proportion of total variance that is attributable to heterogeneity
88
How is heterogeneity dealt with?
Sub group analysis – separate meta analyses
Meta regression - quantify how treatment effect changes with study characteristic
89
What analysis approaches may be performed in an RCT?
Intention to treat
Per protocol
As treated
90
What is a sensitivity analysis?
Assesses the impact of different assumptions and methodological choices on the results of the primary analysis
Can looks at differences in analysis approach, inclusion criteria, outcome definition, missing data
May also be good for missing data – can account for it using imputation
91
What groups are responsible for overseeing a trial?
Trial management group – day to day
Data monitoring committee – independent – make recommendations. Perform formal interim analysis – stop trial if efficacy clear or serious adverse events
Trial steering committee – uses recommendation of DMC
92
What are the issues with a formal interim analysis?
May stop trial prematurely due to random variation in treatment effect over time
93
What is PPV?
Likelihood of people who test positive actually having disease
TP/TP + FP
94
What is NPV?
Likelihood of people who test negative actually not having disease
TN/TN + FN
95
What is heterogeneity?
the degree of difference between methodology in the studies and thus the treatment effect being measured
96
What does asymmetry in a funnel plot (meta analysis) suggest and what does it lead to?
publication bias (only studies that get good results are published)
Leads to overestimation of the treatment effect
97
How do you overcome publication bias?
Register trial beforehand
Publish a protocol
98
What is clinical equipoise?
a state of genuine uncertainty on the part of the clinical investigator regarding the comparative therapeutic merits of each arm in a trial
99
What is Ecological fallacy and give an example
Assuming that the results of a cross sectional study relate to an individual. Eg areas with higher salt consumption are more at risk of heart attacks. Does amount of salt consumption actually increase likelihood in an individual?
100
How can you graphically represent a meta analysis?
Forest plot
101
What is the difference between a retrospective cohort study and a case control study?
case control takes patients based on outcome status whereas retrospective cohort doesn’t
102
Disadvantage of retrospective cohort study?
Potential to find reverse causality
Recall and interviewer bias
103
Disadvantage of using 2:1 allocation?
Undermines clinical equipoise and can cause therapeutic mis-estimation
Reduces power or requires 12% more participants
Affects internal validity
104
Advantages of using 2:1 allocation?
In early phase trials to determine clinical utility
If a tx is particularly expensive
Need for additional safety info - good for adverse events
105
How to interpret a confidence interval looking at the difference between 2 groups?
If it contains the value 0 then p>0.05
106
How to interpret a confidence interval when comparing groups using a ratio instead of a difference e.g. odds/RR?
If it contains the value 1 then p>0.05
107
Difference between OR and RR?
odds ratio is a ratio of two odds whereas the relative risk is a ratio of two probabilities
108
Where can you get research funding from?
Non-commercial:
Research councils - HRA, MRC
Government
NIHR
Charities - CRUK
Commercial:
Pharma companies
Industry companies
109
Where do you apply for ethical approval?
Health Research Authority Research Ethics Committee
110
Which studies is odds ratio used in?
case control
111
What is within participant comparison
Participants are assessed before and after an intervention
Analysis is of the same participant
112
What is a cross-over trial
Participants receive both the intervention and control in a random order
Often is separated by a washout period
113
What is an N-of-1 trial
A single subject trial where an individual is the sole observation
Provides optimal intervention for an individual (e.g. optimal dose)
114
What is a factorial design
Study that investigates multiple independent variables on an outcome measure (both separately and combined)
115
What is a surrogate endpoint
When a biomarker (often easy to measure) is used to predict the likelihood of a clinical outcome
Pros = reduces required follow-up period and sample size and allows measurement when ideal outcome measure is excessively invasive or unethical
Cons = assumes a direct and guaranteed correlation between the biomarker and clinical outcome
116
What is a composite endpoint
Where multiple clinical events/outcomes are combined to form the primary outcome e.g. composite cardiovascular endpoints (unstable angina, stroke and MI)
Pros = allows for higher event rate so need shorter trial and fewer participants suitable when individual events occur infrequently
Cons = distribution of events may be unclear, main driver may be less severe/clinically relevant
117
Advantages and disadvantages of an RCT
Advantages:
- Gold standard for identification of treatment effects
- Prospective design that can infer causality
- Compares otherwise identical groups
- Allows for meta analyses later on
- Unbiased distribution of confounders
- Blinding more likely
Disadvantages:
- May be underpowered
- Expensive: time and money
- Volunteer bias
- Ethically problematic at times
- Surrogate outcomes may not reflect outcomes that are important to patients
118
Advantages and disadvantages of cross-sectional study
A study that examines the relationship between diseases (or other health-related characteristics) and other variables of interest as they exist in a defined population at one particular time (ie exposure and outcomes are both measured at the same time). Best for quantifying the prevalence of a disease or risk factor, and for quantifying the accuracy of a diagnostic test - is descriptive and may be a survey
Advantages:
- Identifies trends
- Cheap and fast
Disadvantages:
- Static
- Does not deduce causality on association at best
